Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies

Cancer Treatment Reviews

Volumn 38, Issue 2, 2012, Pages 111-119

  Bonet Beltrán, Marta ^a,d   Allal, Abdelkarim S ^b   Gich, Ignasi ^c   Solé, Josep M ^a   Carrió, Ignasi ^c,d  

^a Brain   (Spain)

^b Hopital Cantonal de Fribourg   (Switzerland)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Adjuvant radiotherapy; Extrahepatic bile duct cancer; Extrahepatic cholangiocarcinoma

Indexed keywords

FLUOROURACIL;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; EXTRAHEPATIC CHOLANGIOCARCINOMA; GALLBLADDER CANCER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL OBSTRUCTION; HEPATOBILIARY SYSTEM CANCER; HUMAN; INTRAOPERATIVE RADIOTHERAPY; LONGITUDINAL STUDY; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PURE AMPULLARY CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; THREE DIMENSIONAL IMAGING;

ADOLESCENT; ADULT; AGED; BILE DUCTS, EXTRAHEPATIC; BILIARY TRACT NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; YOUNG ADULT;

EID: 84856356085     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2011.05.003     Document Type: Review

References (53)

1. Cancer mondial. International Agency for research in cancer, available from: [last consulted on 19.02.2010]. http://www-dep.iarc.fr.
2. Cleary S.P., Dawson L.A., Knox J.J., et al. Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg 2007, 44:396-482.
3. World Health Organization. International statistical classification of diseases and related health problems. 10th Revision. Instruction Manual. Geneva: World Health Organization; 2004.
4. Jarnagin W.R., Ruo L., Little S.A., et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003, 98:1689-1700.
5. Park S.W., Park Y.S., Chung J.B., et al. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection. Hepatogastroenterology 2004, 51:1612-1618.
6. de Castro S.M., Kuhlmann K.F., van Heek N.T., et al. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. J Gastrointest Surg 2004, 8:775-784.
7. Bridgewater J., Imber C. New advances in the management of biliary tract cancer. HPB (Oxford) 2007, 9:104-111.
8. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999, 230:776-782.
9. Sackett D.L., Strauss S.E., Richardson W.S., et al. Evidence-based medicine how to practice and teach EBM 2000, Churchill Livingstone, New York. 2nd ed.
10. Fisher W.E., Bakey M.E. Differences between ampullary, periampullary and pancreatic cancer. World J Surg 2007, 31:144-146.
11. MacLehose R.R., Reeves B.C., Harvey I.M., et al. A systematic review of comparisons of effect sizes derived from randomised and nonrandomized studies. Health Technol Assess 2000, 4:1-154.
12. Tierney J.F., Stewart L.A., Ghersi D., et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007, 7:8-16.
13. Bax L., Yu L.M., Ikeda N., et al. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006, 13:6-50.
14. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Onkologie 2000, 23:597-602.
15. Bhatia S., Miller R.C., Haddock M.G., et al. Adjuvant therapy for ampullary carcinomas: the Mayo clinic experience. Int J Radiat Oncol Biol Phys 2006, 66:514-519.
16. Borghero Y., Crane C.H., Szklaruk J., et al. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 2008, 15:3147-3156.
17. Czito B.G., Hurwitz H.I., Clough R.W., et al. Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 2005, 62:1030-1034.
18. Dinant S., Gerhards M.F., Rauws E.A., et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 2006, 13:872-880.
19. Gerhards M.F., van Gulik T.M., González González D., et al. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 2003, 27:173-179.
20. Hernandez J., Cowgill S.M., Al-Saadi S., et al. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection. Ann Surg Oncol 2008, 15:807-814.
21. Heron D.E., Stein D.E., Eschelman D.J., et al. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Am J Clin Oncol 2003, 26:422-428.
22. Hughes M.A., Frassica D.A., Yeo C.J., et al. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys 2007, 68:178-182.
23. Itoh H., Nishijima K., Kurosaka Y., et al. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder. Dig Dis Sci 2005, 50:2231-2242.
24. Lee J.H., Whittington R., Williams N.N., et al. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 2000, 47:945-953.
25. Madariaga J.R., Iwatsuki S., Todo S., et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998, 227:70-79.
26. Mahantshetty U.M., Palled S.R., Engineer R., et al. Adjuvant radiation therapy in gall bladder cancers: 10 years experience at Tata Memorial Hospital. J Cancer Res Ther 2006, 2:52-56.
27. Mehta V.K., Fisher G.A., Ford J.M., et al. Adjuvant chemoradiotherapy for " unfavorable" carcinoma of the ampulla of vater: preliminary report. Arch Surg 2001, 136:65-69.
28. Oh D., Lim do H., Heo J.S., et al. The role of adjuvant radiotherapy in microscopic tumor control after extrahepatic bile duct cancer surgery. Am J Clin Oncol 2007, 30:21-25.
29. Pitt H.A., Nakeeb A., Abrams R.A., et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 1995, 221:788-797.
30. Sagawa N., Kondo S., Morikawa T., et al. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg Today 2005, 35:548-552.
31. Sikora S.S., Balachandran P., Dimri K., et al. Adjuvant chemo-radiotherapy in ampullary cancers. Eur J Surg Oncol 2005, 31:158-163.
32. Todoroki T., Ohara K., Kawamoto T., et al. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 2000, 46:581-587.
33. Zervos E.E., Osborne D., Goldin S.B., et al. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg 2005, 190:810-815.
34. Zervos E.E., Pearson H., Durkin A.J., et al. In continuity hepatic resection for advanced hilar cholangiocarcinoma. Am J Surg 2004, 188:584-588.
35. Kim S., Kim S.W., Bang Y.J., et al. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2002, 54:414-419.
36. Krishnan S., Rana V., Evans D.B., et al. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. Int J Radiat Oncol Biol Phys 2008, 70:735-743.
37. Cheng Q., Luo X., Zhang B., et al. Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival. Eur J Surg Oncol 2007, 33:202-207.
38. Beger H.G., Treitschke F., Gansauge F., et al. Tumor of the ampulla of vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999, 134:526-532.
39. Chan S.Y., Poon R.T., Lo C.M., et al. Management of carcinoma of the gallbladder: a single-institution experience in 16 years. J Surg Oncol 2008, 97:156-164.
40. Demetriades H., Zacharakis E., Kirou I., et al. Local excision as a treatment for tumors of ampulla of vater. World J Surg Oncol 2006, 8:4-14.
41. Fong Y., Jarnagin W., Blumgart L.H. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000, 232:557-569.
42. Kim R.D., Kundhal P.S., McGilvray I.D., et al. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 2006, 202:112-119.
43. Konstadoulakis M.M., Roayaie S., Gomatos I.P., et al. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg 2008, 196:160-169.
44. Sakamoto Y., Kosuge T., Shimada K., et al. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 2005, 137:396-402.
45. Scheingraber S., Justinger C., Stremovskaia T., et al. The standardized surgical approach improves outcome of gallbladder cancer. World J Surg Oncol 2007, 5:55.
46. Shimizu H., Kimura F., Yoshidome H., et al. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification. J Hepatobiliary Pancreat Surg 2007, 14:358-365.
47. Todoroki T., Koike N., Morishita Y., et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of vater. Ann Surg Oncol 2003, 10:1176-1183.
48. Yagi H., Shimazu M., Kawachi S., et al. Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection. J Hepatobiliary Pancreat Surg 2006, 13(6):530-536.
49. Klempnauer J., Ridder G.J., Werner M., et al. What constitutes long-term survival after surgery for hilar cholangiocarcinoma?. Cancer 1997, 79:26-34.
50. Mojica P., Smith D., Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 2007, 96:8-13.
51. Wang S.J., Fuller C.D., Kim J.S., et al. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 2008, 26:2112-2117.
52. Zaydfudim V., Feurer I.D., Wright J.K., et al. The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma. HPB (Oxford) 2008, 10:420-427.
53. Concato J., Shah N., Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000, 342:1887-1892.